Medical cannabis products were exported from Israel for the first time this week, one year after the government approved overseas sales, Revadim-based BOL Pharma said on Tuesday.
BOL Pharma, a IMC-GMP-certified cultivator and supplier of medical cannabis, said it exported its first batch of medical cannabis to a customer in the United Kingdom.
The products are destined for centers that specialize in the treatment of children with epilepsy and autism.
Click here to read the complete article
Eytan Halon ~ Jerusalem Post ~
